Divine Medipharma Private Limited
About Divine Medipharma Private Limited
Data last updated:
Divine Medipharma Private Limited is a private limited company based in Haridwar, Uttarakhand, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 20 December 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74120UR2010PTC033348. Its GSTIN is 09AADCD6691A1ZP (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Satendra Singh (Managing Director) and Sunder Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P39 Iiird Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403.
As per the financials filed for FY 2024, the company reported a revenue of ₹10.8 Lakh, a growth of 51% compared to the previous year. For the same year it recorded a net profit of ₹2,170 (net margin 0.2%) and EBITDA of ₹2,170 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 88% over three years and 46% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Divine Medipharma Private Limited's registered office is in Haridwar, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP39 Iiird Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Divine Medipharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Divine Medipharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Divine Medipharma Private Limited, buy the company report.
Financials of Divine Medipharma Private Limited
FY 2025 filings availableDivine Medipharma Private Limited reported revenue of ₹10.8 Lakh (up 51% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 46% over five years, including 51% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2,170 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,170 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Divine Medipharma Private Limited, buy the company report.
Board of directors of Divine Medipharma Private Limited
Divine Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunder Singh | Director | 20 Dec 2010 | 15 Years 10 Months | Current |
| Satendra Singh | Managing Director | 20 Dec 2010 | 15 Years 10 Months | Current |
Peer comparison
Divine Medipharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SSKV Pharmaceutical Private Limited | ₹10.83 Lakh (FY 2025) | -11.0% | Pratapgarh, Uttar Pradesh, India | |||
| Rosson Health Care India Private Limited | ₹10.83 Lakh (FY 2024) | 62.0% | Coimbatore, Tamil Nadu, India | |||
| Aquinique Healthcare Private Limited | ₹10.82 Lakh (FY 2024) | 17.0% | Muzaffarpur, Bihar, India | |||
| Chemrena Pharma Private Limited | ₹10.81 Lakh (FY 2024) | Sarkaghat, Himachal Pradesh, India | ||||
| Chandrabhan Industrial Metallic India Private Limited | ₹10.81 Lakh (FY 2025) | -88.0% | Satna, Madhya Pradesh, India | |||
| Divine Medipharma Private Limitedthis company | ₹10.8 Lakh (FY 2024) | ₹2,170 | 0.2% | 51.0% | Haridwar, Uttarakhand, India | |
| Ahumanrez Neuro Pharma Private Limited | ₹10.8 Lakh (FY 2022) | 104.0% | Jaipur, Rajasthan, India | |||
| Tenocin Pharmaceuticals Private Limited | ₹10.79 Lakh (FY 2024) | -15.0% | Noida, Uttar Pradesh, India | |||
| Alegic Pharmaceuticals Private Limited | ₹10.78 Lakh (FY 2025) | -9.0% | Ahmedabad, Gujarat, India | |||
| H.K. Paper Industries Pvt Ltd | ₹10.75 Lakh (FY 2024) | 11.0% | Alwar, Rajasthan, India | |||
| Heat Shield Private Limited | ₹10.74 Lakh (FY 2021) | Ahmedabad, Gujarat, India |
To see the full peer comparison of Divine Medipharma Private Limited, buy the company report.
Auditor
Divine Medipharma Private Limited is audited by RAJEEVVARSHNEY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJEEVVARSHNEY | FY 2017 | 400043 |
Shareholding
The shareholding of Divine Medipharma Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Divine Medipharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Divine Medipharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Divine Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Divine Medipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCD6691A1ZP | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Divine Medipharma Private Limited, buy the company report.
Recent activity
Divine Medipharma Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Satendra Singh was appointed as Managing Director on 20 Dec 2010.
Frequently asked questions
Divine Medipharma is an active private limited company based in Haridwar, Uttarakhand, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 20 December 2010 (16+ years old) and is registered under CIN U74120UR2010PTC033348.
Divine Medipharma has 2 current directors:
- Satendra Singh - Managing Director
- Sunder Singh - Director
The latest financial statements of Divine Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Divine Medipharma is 09AADCD6691A1ZP, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Divine Medipharma is U74120UR2010PTC033348. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Divine Medipharma was incorporated on 20 December 2010, making it 16+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Divine Medipharma by revenue are SSKV Pharmaceutical Private Limited, Rosson Health Care India Private Limited, Aquinique Healthcare Private Limited, Chemrena Pharma Private Limited, Chandrabhan Industrial Metallic India Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Satendra Singh was appointed as Managing Director on 20 Dec 2010. Sunder Singh was appointed as Director on 20 Dec 2010.
The registered office of Divine Medipharma is at P39 Iiird Shivalik Nagar Bhel, Haridwar, Uttarakhand, India – 249403.
Divine Medipharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Divine Medipharma is compliant as of 03 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
